CYTOPLASMIC EXPRESSION OF THE C-ERBB-2 GENE IS ASSOCIATED WITH POOR-PROGNOSIS IN DUKES-B COLORECTAL-CANCER

被引:0
|
作者
MULCAHY, H
KAY, E
LEADER, M
ODONOGHUE, DP
机构
[1] ST VINCENTS HOSP,GASTROENTEROL & LIVER UNIT,DUBLIN 4,IRELAND
[2] ROYAL COLL SURGEONS IRELAND,DEPT PATHOL,DUBLIN 2,IRELAND
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A418 / A418
页数:1
相关论文
共 50 条
  • [41] c-erbB-2 Positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease
    Jukkola, A
    Bloigu, R
    Soini, Y
    Savolainen, ER
    Holli, K
    Blanco, G
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (03) : 347 - 354
  • [42] Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer
    Zhang, H
    Sun, XF
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (01) : 49 - 52
  • [43] Amplification of c-erbB-2 gene in female breast cancer
    Zadrozny, M
    Smolarz, B
    Romanowicz-Makowska, H
    Kozlowska, E
    Kulig, A
    EXPERIMENTAL ONCOLOGY, 2002, 24 (03): : 198 - 202
  • [44] NFAT regulates a gene expression program associated with invasiveness and poor prognosis in colorectal cancer
    Tripathi, Manish K.
    Mima, Shinji
    Shi, Zhiao
    Prodduturi, Naresh
    Jing, Zhu
    Clombor, Kristen K.
    Chen, Xi
    Daana, Natasha
    Beauchamp, Robert D.
    Zhang, Bing
    CANCER RESEARCH, 2013, 73
  • [45] EXPRESSION AND SIGNIFICANCE OF C-erbB-2 IN THE TISSUES OF LUNG CANCER
    李西平
    王洁
    王曾礼
    刘叙仪
    蒋薇
    Journal of Xi'an Medical University, 2001, (01) : 53 - 55
  • [46] CONTRIBUTION OF PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS TO THE SURVIVAL PROGNOSIS OF PATIENTS WITH DUKES STAGE-B AND STAGE-C COLORECTAL-CANCER
    GANESH, S
    SIER, CFM
    HEERDING, MM
    VANKRIEKEN, JHJM
    GRIFFIOEN, G
    VANDEVELDE, CJH
    LAMERS, CBHW
    VERSPAGET, HW
    GASTROENTEROLOGY, 1995, 108 (04) : A472 - A472
  • [47] EGFR and c-erbB-2 expression in breast cancer progression
    Chong, D
    Reeves, J
    Cooke, T
    George, WD
    Mallon, E
    Ozanne, B
    Stanton, P
    BRITISH JOURNAL OF CANCER, 1998, 78 : 24 - 24
  • [48] C-ERBB-2 ONCOGENE EXPRESSION IN OVARIAN-CANCER
    HALDANE, JS
    HIRD, V
    HUGHES, CM
    GULLICK, WJ
    JOURNAL OF PATHOLOGY, 1990, 162 (03): : 231 - 237
  • [49] Cytoplasmic Pin1 expression is correlated with poor prognosis in colorectal cancer
    Pyo, Jung-Soo
    Son, Byoung Kwan
    Oh, Il Hwan
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (11) : 1848 - 1853
  • [50] EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN GASTRIC-CARCINOMA - IMMUNOREACTIVITY FOR C-ERBB-2 PROTEIN IS AN INDEPENDENT INDICATOR OF POOR SHORT-TERM PROGNOSIS IN PATIENTS WITH GASTRIC-CARCINOMA
    YONEMURA, Y
    NINOMIYA, I
    OHOYAMA, S
    KIMURA, H
    YAMAGUCHI, A
    FUSHIDA, S
    KOSAKA, T
    MIWA, K
    MIYAZAKI, I
    ENDOU, Y
    TANAKA, M
    SASAKI, T
    CANCER, 1991, 67 (11) : 2914 - 2918